Where does ViiV Healthcare UK (No.5) Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ViiV Healthcare UK (No.5) Limited ranks #6,605 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ViiV Healthcare UK (No.5) Limited hold?

ViiV Healthcare UK (No.5) Limited holds 51 US utility patents granted between 2016 and 2024, spanning 9 technology areas.

What is ViiV Healthcare UK (No.5) Limited's Innovation Score?

ViiV Healthcare UK (No.5) Limited has an Innovation Score of 34.8 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is ViiV Healthcare UK (No.5) Limited's patent grant rate increasing or decreasing?

ViiV Healthcare UK (No.5) Limited's recent grant velocity is -62% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ViiV Healthcare UK (No.5) Limited's patents?

ViiV Healthcare UK (No.5) Limited's patents average 11.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ViiV Healthcare UK (No.5) Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ViiV Healthcare UK (No.5) Limited

Q: What technology areas does ViiV Healthcare UK (No.5) Limited focus on?

ViiV Healthcare UK (No.5) Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 48 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 51 granted patents across 9 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Viiv ranks #6,605 of 49,997 tracked US assignees by granted-patent volume, with 51 patents across 9 technology areas.

#6,605
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.8/100): 11.4
avg claims per patent: -62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6605 · Foreign Corporation #6,605 · 51 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 51 grants
UPPER-Q #6,605/49,997
PHOTO-FINISH Tower Manufacturing
CPC-NARROW A61P · 9 areas
INNOV-THIN 34.8/100
CLAIMS-PAR 11.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -62% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tower Manufacturing Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Javad Gnss · near

35
Varonis Systems · near

35
ViiV Healthcare UK… · this assignee

35
Hamilton Associates · near

35
Kotobuki & · near

35
3D Lighting… · lowest

7

What this shows Viiv's Innovation Score is 34.8/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Viiv's grants concentrate

ViiV Healthcare UK (No.5) Limited is a focused PatentsView assignee: 9 CPC subclasses with 94.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (15 grants) versus a trough of 1 in 2023. By volume, Viiv sits between Tower Manufacturing Corp. and Yoshino Gypsum Co., Ltd..

Viiv's three-year grant acceleration

ViiV Healthcare UK (No.5) Limited shows 9 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tower Manufacturi…

51
University OF Lei…

51
VTV Therapeutics

51
Vestel Elektronik…

51
Waldemar Link & KG

51
Wapp Tech

51
Xenon Pharmaceuti…

51
Yoshino Gypsum

51
Viiv Healthcare U… ◀

51

What this shows ViiV holds 51 patents at rank #6,606, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ViiV

By rank, the assignees closest to #6,606 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in ViiV's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for ViiV, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Varonis Systems, Inc. 35 Javad Gnss, Inc. 35 Kotobuki & Co., Ltd. 35 Hamilton Associates, Inc. 35

Similar claim depth

Nearest assignees by average claims per patent (11.4 here).

Shenzhen Carku Technology Co., Limited 11.4 avg R A Brands L.L.C. 11.4 avg Fujian Jinhua Integrated Circuit Co., Ltd. 11.4 avg Panduit Corp. 11.4 avg

Viiv's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

ViiV Healthcare UK (No.5) Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	5.9%
2017	8	15.7%
2018	15	29.4%
2019	11	21.6%
2020	2	3.9%
2021	3	5.9%
2022	3	5.9%
2023	1	2.0%
2024	5	9.8%

Which technologies does ViiV Healthcare UK (No.5) Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 48

C07D - Heterocyclic Compounds 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 33

C07J - Steroids 11

C07C - Acyclic OR Carbocyclic Compounds 8

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C07K - Peptides 2

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#6,605

of 49,997 tracked assignees

Innovation Score

34.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

ViiV Healthcare UK (No.5) Limited's patent record in context - here's where to go next.

ViiV Healthcare UK (No.5) Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 94.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,605 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ViiV Healthcare UK (No.5) Limited against Tower Manufacturing Corp., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.